uric acid has been researched along with oxidopamine in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Carey, RJ; Dai, H; Huston, JP; Pinheiro-Carrera, M; Tomaz, C | 1 |
| Church, WH; Fong, YT | 1 |
| Gibson, A; Lilley, E | 1 |
| Brundin, P; Castilho, RF; DiFiglia, M; Hansson, O; Petersén, A; Przedborski, S; Puschban, Z; Rice, M; Romero, N; Sapp, E; Sulzer, D | 1 |
| Korkach, IuP; Kotsiuruba, AV; Sahach, VF; Talanov, SA | 1 |
| Huang, TT; Liu, CF; Luo, WF; Wang, XX; Xu, XS; Zhang, QL; Zhu, TG | 1 |
| Burdett, TC; Chen, X; Cipriani, S; Desjardins, CA; Logan, R; Schwarzschild, MA; Xu, Y | 1 |
| Hu, LF; Huang, T; Li, D; Liu, CF; Luo, WF; Peng, XY; Shu, HY; Zhang, GQ; Zhang, N; Zhang, QL | 1 |
| Haghdoost-Yazdi, H; Khandan-Chelarci, G; Sarukhani, MR | 1 |
| Dohgu, S; Fukae, J; Kataoka, Y; Koga, M; Matsumoto, J; Nakashima, A; Takata, F; Tsuboi, Y; Yamauchi, A | 1 |
| Bi, W; Cheng, Y; Duan, WJ; He, RR; Kurihara, H; Li, SB; Li, WX; Li, YF; Liang, L; Liu, B; Lu, DH; Pan, MH; Wang, TM; Yang, XJ; Zhong, HB | 1 |
11 other study(ies) available for uric acid and oxidopamine
| Article | Year |
|---|---|
L-dopa induced increases in brain uric acid in an animal model of Parkinson's disease: a relationship to behavioral activation.
Topics: Animals; Behavior, Animal; Brain; Disease Models, Animal; Dopamine; Levodopa; Male; Neurons; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sympathectomy, Chemical; Uric Acid; Ventral Tegmental Area | 1994 |
Changes in uric acid during acute infusion of MPP+, 6-OHDA, and FeCl3. A microdialysis study in the substantia nigra of the guinea pig.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Chlorides; Ferric Compounds; Guinea Pigs; Infusions, Intravenous; Male; Microdialysis; Oxidopamine; Substantia Nigra; Uric Acid | 1996 |
Release of the antioxidants ascorbate and urate from a nitrergically-innervated smooth muscle.
Topics: Adrenergic Agents; Animals; Antioxidants; Ascorbic Acid; Male; Muscle Relaxation; Muscle, Smooth; Nitric Oxide; Oxidopamine; Rats; Rats, Wistar; Uric Acid | 1997 |
Mice transgenic for exon 1 of the Huntington's disease gene display reduced striatal sensitivity to neurotoxicity induced by dopamine and 6-hydroxydopamine.
Topics: Aging; Animals; Ascorbic Acid; Dopamine; Dopamine and cAMP-Regulated Phosphoprotein 32; Dose-Response Relationship, Drug; Drug Resistance; Exons; Glutathione; Huntington Disease; Mice; Mice, Knockout; Mice, Transgenic; Microscopy, Electron; Neostriatum; Nerve Tissue Proteins; Neurons; Neurotoxins; Oxidative Stress; Oxidopamine; Phosphoproteins; Quinolinic Acid; Retrograde Degeneration; Substantia Nigra; Superoxide Dismutase; Superoxide Dismutase-1; Uric Acid | 2001 |
[Oxidative stress in the cardiovascular system of rats with chronic deficiency of cerebral dopamine].
Topics: Animals; Cardiovascular System; Cerebral Cortex; Corpus Striatum; Dopamine; Erythrocytes; Lipid Peroxidation; Male; Malondialdehyde; Mitochondria, Heart; Myocardium; Neurons; Oxidative Stress; Oxidopamine; Rats; Rats, Wistar; Reactive Oxygen Species; Substantia Nigra; Urea; Uric Acid | 2009 |
Protective effects of urate against 6-OHDA-induced cell injury in PC12 cells through antioxidant action.
Topics: Adrenergic Agents; Animals; Antioxidants; Neurons; Oxidative Stress; Oxidopamine; PC12 Cells; Rats; Uric Acid | 2012 |
Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration.
Topics: Allantoin; Analysis of Variance; Animals; Blotting, Western; Brain; Dopamine; Dopaminergic Neurons; Immunohistochemistry; Mice; Mice, Knockout; Mice, Transgenic; Movement; Oxidopamine; Parkinsonian Disorders; Urate Oxidase; Uric Acid | 2013 |
Nrf2 signaling contributes to the neuroprotective effects of urate against 6-OHDA toxicity.
Topics: Active Transport, Cell Nucleus; Cell Line; Cell Line, Tumor; Dopaminergic Neurons; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Hydrogen Peroxide; Models, Biological; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidopamine; Protein Transport; Proteolysis; RNA Interference; Signal Transduction; Transcription, Genetic; Ubiquitination; Uric Acid | 2014 |
Changes in the Serum Urate Level Can Predict the Development of Parkinsonism in the 6-Hydroxydopamine Animal Model.
Topics: Animals; Apomorphine; Biomarkers; Cell Death; Dopamine; Dopamine Agonists; Male; Neurons; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Predictive Value of Tests; Rats; Rats, Wistar; Substantia Nigra; Tyrosine 3-Monooxygenase; Uric Acid | 2018 |
Feeding-produced subchronic high plasma levels of uric acid improve behavioral dysfunction in 6-hydroxydopamine-induced mouse model of Parkinson's disease.
Topics: Adrenergic Agents; Animals; Apomorphine; Disease Models, Animal; Hyperuricemia; Male; Mental Disorders; Mice; Mice, Inbred ICR; Motor Activity; Oxidopamine; Oxonic Acid; Parkinson Disease, Secondary; Rotarod Performance Test; Tyrosine 3-Monooxygenase; Uric Acid | 2019 |
Theacrine, a purine alkaloid from kucha, protects against Parkinson's disease through SIRT3 activation.
Topics: Animals; Apoptosis; Behavior, Animal; Camellia; Dopaminergic Neurons; Embryo, Nonmammalian; Humans; Male; Mice, Inbred C57BL; Mitochondria; Neuroprotective Agents; Oxidopamine; Parkinsonian Disorders; Rats, Sprague-Dawley; Sirtuin 1; Uric Acid; Zebrafish | 2020 |